Clinical Research Organization (CRO)

Dor Pharmaceutical Services provides full Clinical Research Organisation (CRO) services to coordinate clinical trials at Israel’s leading medical centers. A reliable, knowledgeable clinical development partner, Dor takes care of operational and administrative tasks so companies can focus on verifying product safety and effectiveness. In the complex drug development process, Dor delivers world-class service and support.

Working in close partnership with your team, Dor provides flexible, responsive outsource capabilities tailored to your exact requirements from phase I to IV. Together we evaluate and manage study progress and assist in decision making, solution implementation and resource adaptation. Our focus is always on providing the highest level of service so your product gets to market faster.

Dor’s gold standard clinical study support complements and extends your in-house research and development resources. Our services help you expedite all aspects of your clinical study in Israel, including:

Preparation of study documentation (medical writing: protocol, Investigator’s brochure, informed consent form (CRF), diaries, etc.)

Identifying and evaluating study locations (feasibility studies)

Pre-study selection visits

Investigator and site selection

Budget and contract negotiation

Investigator meeting coordination

Regulatory submissions in compliance with international (ICH-GCP) and local requirements

Site setup and staff training

Study materiel management

Management of study medication supply (including QP batch release) and other logistic issues

Monitoring and Handling of study payments

Site management and outsourced site monitoring

Clinical research organization (CRO) oversight

Adverse event reporting

Translation and localization of clinical trial and medical documents

Conducting clinical studies in Israel with Dor Pharmaceutical Services offers significant advantages

National medical insurance coverage – financial barriers to treatment absent

Single-tier medical service – equal treatment across population

47 teaching hospitals feature high-caliber, modern facilities with technology and treatments at western standards

Excellent traceability through computerized medical records

Highly educated, enthusiastic physicians for strong recruitment rates and very low patient lost-to-follow-up rates

Excellent English proficiency among medical staff for effective communication

Experienced, professional study monitors

High data quality recognized by FDA and EMEA

National guidelines for conducting clinical studies compliant with ICH-GCP and EN-540

Efficient ethical approval process

Compact geography for cost-effective monitoring

Population genetically diverse – Israeli clinical results applicable to most developed countries

Key opinion leaders and local societies/working groups in most medical disciplines

Israel ranked 5th per capita for clinical studies